Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Moderna's President, Stephen Hoge, reported the acquisition and disposal of company stock, including transactions related to restricted stock units and tax obligations.

Summary

• Stephen Hoge, President of Moderna, Inc., filed a Form 4 detailing changes in his beneficial ownership of Moderna stock.
• On March 1, 2024, Hoge converted 652 restricted stock units (RSUs) into common stock.
• Also on March 1, 2024, Hoge directly held 1,516,550 shares of common stock.
• On March 4, 2024, Hoge sold 309 shares at a price of $94.3383 per share to cover tax withholding obligations related to the vesting of RSUs, leaving him with 1,516,241 shares.
• Hoge also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust for the benefit of his spouse and children.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Moderna.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but the overall impact is likely minimal as it is related to tax obligations.

Key Dates